Immunotherapy for recurrent malignant melanoma: Efficacy of BCG in prolonging the postoperative disease free interval and survival

J. U. Gutterman; S. P. Richman; C. M. McBride

doi:10.1007/978-3-642-81332-0_53

Immunotherapy for recurrent malignant melanoma: Efficacy of BCG in prolonging the postoperative disease free interval and survival

J. U. Gutterman, S. P. Richman, C. M. McBride

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

In this report, the authors summarize updated results with adjuvant immunotherapy with bacillus Calmette-Guerin (BCG) for patients with recurrent malignant melanoma. This program was initiated in 1971.

Original language	English (US)
Pages (from-to)	359-362
Number of pages	4
Journal	Recent Results in Cancer Research
Volume	Vol. 68
DOIs	https://doi.org/10.1007/978-3-642-81332-0_53
State	Published - 1979
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-3-642-81332-0_53

Cite this

@article{a2cef9aab98349bb8135aa2ac7bdd95f,

title = "Immunotherapy for recurrent malignant melanoma: Efficacy of BCG in prolonging the postoperative disease free interval and survival",

abstract = "In this report, the authors summarize updated results with adjuvant immunotherapy with bacillus Calmette-Guerin (BCG) for patients with recurrent malignant melanoma. This program was initiated in 1971.",

author = "Gutterman, {J. U.} and Richman, {S. P.} and McBride, {C. M.}",

year = "1979",

doi = "10.1007/978-3-642-81332-0_53",

language = "English (US)",

volume = "Vol. 68",

pages = "359--362",

journal = "Recent Results in Cancer Research",

issn = "0080-0015",

publisher = "Springer New York",

}

TY - JOUR

T1 - Immunotherapy for recurrent malignant melanoma

T2 - Efficacy of BCG in prolonging the postoperative disease free interval and survival

AU - Gutterman, J. U.

AU - Richman, S. P.

AU - McBride, C. M.

PY - 1979

Y1 - 1979

N2 - In this report, the authors summarize updated results with adjuvant immunotherapy with bacillus Calmette-Guerin (BCG) for patients with recurrent malignant melanoma. This program was initiated in 1971.

AB - In this report, the authors summarize updated results with adjuvant immunotherapy with bacillus Calmette-Guerin (BCG) for patients with recurrent malignant melanoma. This program was initiated in 1971.

UR - http://www.scopus.com/inward/record.url?scp=0018213256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018213256&partnerID=8YFLogxK

U2 - 10.1007/978-3-642-81332-0_53

DO - 10.1007/978-3-642-81332-0_53

M3 - Article

C2 - 752870

AN - SCOPUS:0018213256

VL - Vol. 68

SP - 359

EP - 362

JO - Recent Results in Cancer Research

JF - Recent Results in Cancer Research

SN - 0080-0015

ER -

Immunotherapy for recurrent malignant melanoma: Efficacy of BCG in prolonging the postoperative disease free interval and survival

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this